- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06000319
Natural Matrix Protein™ (NMP™) Fibers in Cervical and Lumbar Interbody Fusion
Prospective Evaluation of Natural Matrix Protein™ (NMP™) Fibers in Cervical and Lumbar Interbody Fusion
Study Overview
Status
Detailed Description
The study involves a retrospective review of patients' medical records and prospective collection of X-rays, and patient outcome questionnaires.
The study population will include 100 consecutive lumbar interbody fusion and 100 consecutive cervical interbody fusion patients who meet the inclusion criteria and do not meet the exclusion criteria.
There will be 4 prospective study visits following consent. Follow-up will occur in accordance with standard of care practice and will continue to 12 months post-surgery
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Sean A Peel, Ph.D.
- Phone Number: 416-898-9724
- Email: sean.peel@redrockregen.com
Study Locations
-
-
Alabama
-
Jasper, Alabama, United States, 35501
- Southern Orthopedic Sports Medicine Associates
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Subject was diagnosed with DDD, spinal stenosis, or spondylolisthesis;
- Subject has undergone cervical or lumbar interbody spine fusion at no more than 3 adjacent levels between C2 and T1 or between L1 and S1;
- Subject has undergone cervical or lumbar interbody spine fusion using NMP Fibers;
- Subject must be 18 years of age or older at the time of consent;
- Subject must be willing and able to sign an informed consent document;
- Subject must be willing and able to return to the study clinic for all follow-up visits, agree to participate in post-operative clinical and radiographic evaluations.
Exclusion Criteria:
- Subject is under 18 years of age at the time of consent;
- Subject is currently experiencing major mental illness (psychosis, schizophrenia, major affective disorder) which in the opinion of the investigator may indicate that the symptoms are psychological rather than of physical origin;
- Subject is currently imprisoned.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Lumbar Interbody Fusion with NMP
Subject has undergone lumbar interbody spine fusion at no more than 3 adjacent levels between L1 and S1 where NMP fibers have been used as a bone void filler
|
human bone allograft
Procedure that involves removing the intervertebral disk from the disk space between between 2 or more vertebrae between L1 and S1.
When the disk space has been cleared out, the surgeon fills the void between the vertebrae with a bone void filler.
|
Cervical Interbody Fusion with NMP
Subject has undergone cervical interbody spine fusion at no more than 3 adjacent levels between C2 and T1 where NMP fibers have been used as a bone void filler
|
human bone allograft
Procedure that involves removing the intervertebral disk from the disk space between between 2 or more vertebrae between C2 and T1.
When the disk space has been cleared out, the surgeon fills the void between the vertebrae with a bone void filler.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of interbody fusion
Time Frame: Baseline to 12 months post-operative
|
Flexion and Extensions radiographs will be assessed for fusion at each level to be fused Fusion is defined as: (1) less than 5 degrees of motion by flexion extension X-ray and (2) no radiological features of non-union (radiolucency, implant migration, loss of graft height, supplemental fixation failure).
Both fusion criteria have to be met to be considered a fusion success at the index level.
|
Baseline to 12 months post-operative
|
Incidence of secondary surgical intervention
Time Frame: Baseline to 12 months post-operative
|
Secondary surgical interventions (SSI) include revision, re-operation, removal, or supplemental fixation at the index levels
|
Baseline to 12 months post-operative
|
Incidence of Adverse Product Related Events
Time Frame: Baseline to 12 months post-operative
|
the incidence of the following will be reported: bone resorption with cage migration or subsidence, local inflammation with seromas, ectopic bone formation, radiculitis.
|
Baseline to 12 months post-operative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of bridging bone
Time Frame: Baseline to 12 months post-operative
|
Plane radiographs will be evaluated for the presence of bridging bone at each level to be fused.
|
Baseline to 12 months post-operative
|
Change in disability score for lumbar fusion patients assessed by Oswestry Disability Index
Time Frame: Baseline to 12 months post-operative
|
Disability will be assessed using the Oswestry Disability Index (ODI).
ODI is a questionnaire to collect a patient's responses to questions about perceived function (disability) in 10 everyday activities in patients with acute or chronic low back pain.
Each question consists of 6 statements about 1 activity which are scored from 0 to 5. With 0 indicating the least disability and 5 the greatest.
The scores are combined to a single score from 0 (no disability) to 50 (completely disabled)
|
Baseline to 12 months post-operative
|
Change in disability score for cervical fusion patients assessed by Neck Disability Index
Time Frame: Baseline to 12 months post-operative
|
Disability will be assessed using the Neck Disability Index (NDI).
NDI is a questionnaire to collect a patient's responses to questions about perceived function (disability) in 10 everyday activities in patients with acute or chronic neck pain.
Each question consists of 6 statements about 1 activity which are scored from 0 to 5. With 0 indicating the least disability and 5 the greatest.
The scores are combined to a single score from 0 (no disability) to 50 (completely disabled)
|
Baseline to 12 months post-operative
|
Change in back pain in lumbar fusion patients
Time Frame: Baseline to 12 months post-operative
|
Pain will be assessed by Visual Analogue Scale (VAS) for back pain.
VAS is a straight horizontal line of fixed length.
The ends are defined as the extreme limits of the pain to be measured from the left (no pain) to the right (worst pain imaginable) and the patient marks on the line how much pain they are experiencing at that time.
The VAS score is determined by measuring in millimeters from the end of the line to the point that the patient marks.
The minimum score is 0 and the maximum score is 100.
The larger the number the worse the pain being experienced
|
Baseline to 12 months post-operative
|
Change in leg pain in lumbar fusion patients
Time Frame: Baseline to 12 months post-operative
|
Pain will be assessed by Visual Analogue Scale (VAS) for back pain.
VAS is a straight horizontal line of fixed length.
The ends are defined as the extreme limits of the pain to be measured from the left (no pain) to the right (worst pain imaginable) and the patient marks on the line how much pain they are experiencing at that time.
The VAS score is determined by measuring in millimeters from the end of the line to the point that the patient marks.
The minimum score is 0 and the maximum score is 100.
The larger the number the worse the pain being experienced.
|
Baseline to 12 months post-operative
|
Change in neck pain in cervical fusion patients
Time Frame: Baseline to 12 months post-operative
|
Pain will be assessed by Visual Analogue Scale (VAS) for back pain.
VAS is a straight horizontal line of fixed length.
The ends are defined as the extreme limits of the pain to be measured from the left (no pain) to the right (worst pain imaginable) and the patient marks on the line how much pain they are experiencing at that time.
The VAS score is determined by measuring in millimeters from the end of the line to the point that the patient marks.
The minimum score is 0 and the maximum score is 100.
The larger the number the worse the pain being experienced.
|
Baseline to 12 months post-operative
|
Change in arm pain in cervical fusion patients
Time Frame: Baseline to 12 months post-operative
|
Pain will be assessed by Visual Analogue Scale (VAS) for back pain.
VAS is a straight horizontal line of fixed length.
The ends are defined as the extreme limits of the pain to be measured from the left (no pain) to the right (worst pain imaginable) and the patient marks on the line how much pain they are experiencing at that time.
The VAS score is determined by measuring in millimeters from the end of the line to the point that the patient marks.
The minimum score is 0 and the maximum score is 100.
The larger the number the worse the pain being experienced.
|
Baseline to 12 months post-operative
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Mark A Prevost Sr, MD, Southern Orthopedic Sports Medicine Associates
- Principal Investigator: Mark A Prevost II, MD, Southern Orthopedic Sports Medicine Associates
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CT-NMP-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Degenerative Disc Disease
-
Assistance Publique - Hôpitaux de ParisTerminatedCervical Degenerative Disc Disease | Kyphosis | Lumbar Degenerative Disc DiseaseFrance
-
Assiut UniversityNot yet recruiting
-
Spine BioPharma, IncMCRARecruitingLumbar Degenerative Disc DiseaseUnited States
-
AxioMed Spine CorporationUnknownDegenerative Disc Disease (DDD)United States, Germany
-
Synthes USA HQ, Inc.CompletedLumbar Degenerative Disc Disease
-
DePuy InternationalTerminatedCervical Degenerative Disc DiseaseAustralia, Germany, Italy, Malaysia, Netherlands, Spain, United Kingdom
-
Synergy Spine SolutionsMCRARecruitingCervical Degenerative Disc DiseaseUnited States
-
Orthofix Inc.TerminatedCervical Degenerative Disc DiseaseUnited States
-
Yuhan CorporationCompletedDisc Degenerative DiseaseKorea, Republic of
-
Synergy Spine SolutionsMCRANot yet recruitingCervical Degenerative Disc DiseaseUnited Kingdom
Clinical Trials on Natural Matrix Protein (NMP) Fibers
-
Induce Biologics USA Inc.Enrolling by invitation
-
T.C. Dumlupınar ÜniversitesiCompletedBone Density Increased | Osseointegration Failure of Dental ImplantTurkey
-
SeaSpine, Inc.Active, not recruiting
-
Kaiser PermanenteCompletedMalnutrition | Hypoalbuminemia | Peritoneal Dialysis ComplicationUnited States
-
University of PadovaCompletedHormone | Insulin Tolerance | Aminoacidaemia
-
Lawson Health Research InstituteCompleted
-
University of TorontoHeart and Stroke Foundation of Ontario; Orafti GroupCompletedCardiovascular Disease | Hyperlipidemia | Diet TherapyCanada
-
Aziyo Biologics, Inc.WithdrawnDegenerative Disc Disease | Spondylolisthesis | Retrolisthesis
-
University of CopenhagenCompleted
-
Instituto Tecnologico y de Estudios Superiores...Completed